Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema
about
The role of brimonidine tartrate gel in the treatment of rosaceaSkin barrier in rosaceaMultidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine TherapyImproving Treatment of Erythematotelangiectatic Rosacea with Laser and/or Topical Therapy Through Enhanced Discrimination of its Clinical FeaturesMajor pathophysiological correlations of rosacea: a complete clinical appraisalPreliminary open-label clinical evaluation of the soothing and reepithelialization properties of a novel topical formulation for rosacea.Augmented supraorbital skin sympathetic nerve activity responses to symptom trigger events in rosacea patients.The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea.Corneal and conjunctival sensitivity in rosacea patients.Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefitSpotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptabilityThe Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey.Rosacea fulminans: unusual clinical presentation of rosacea.Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea.
P2860
Q26777249-455A87DC-E4A7-445E-AAC1-9D6303A93111Q28069342-41E56051-D71A-47BE-8CF6-0415C4997001Q28077384-4F33C9FA-D6FD-49EC-9614-1C9EAF4262D5Q28077479-D542DAD5-69C9-4ED5-A882-67A26F4608A8Q28082171-B6F4D550-370E-4B37-AAEC-9F8F2EBE8852Q34434776-46986CDD-34D5-4D19-B0A7-4EFEC685C6E4Q35680501-1B5E68D5-6017-44B9-AA9F-D540CBECCB08Q36087360-D673BCD6-47B8-4088-BCE4-D37E471B265EQ36595369-51ADE536-F411-4A39-B21F-7357BA59F117Q37595472-69AC502B-EF4A-4DC3-A9CE-F41B9CE6C874Q38663455-03114A4F-179C-40EA-B0DE-4738F560E31FQ42045644-AFADC0AA-AA8B-4C18-A5AE-5F9B6D8E9ACDQ42319954-1970A80F-1563-402D-9C34-BFE7BC67B944Q43379739-5B54D140-A6FA-48D9-AA37-8FF3FFABF46EQ55340442-C97CC9A5-FED1-446B-BCBE-19E5B1B93A4C
P2860
Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Advances in understanding and ...... ar changes and facial erythema
@ast
Advances in understanding and ...... ar changes and facial erythema
@en
type
label
Advances in understanding and ...... ar changes and facial erythema
@ast
Advances in understanding and ...... ar changes and facial erythema
@en
prefLabel
Advances in understanding and ...... ar changes and facial erythema
@ast
Advances in understanding and ...... ar changes and facial erythema
@en
P2860
P1476
Advances in understanding and ...... ar changes and facial erythema
@en
P2093
James Q Del Rosso
P2860
P577
2012-03-01T00:00:00Z